Scott Power

Senior Analyst for the Healthcare, Life Science, Telecommunications, Technology and Media sectors at Morgans.

[Morgans Financial Limited @morgansAU]

Healthcare update - Monash ($MVF), Virtus ($VRT) and 3 emerging healthcare names: http://t.co/9H2ibPY7s5 #ASX #ausbiz

[Scott Power @ScottPowerSays]

My interview with Michael Kavanagh, CEO and President of Nanosonics ($NAN): http://t.co/qlhUbp9kZm #ASX #ausbiz

[Scott Power @ScottPowerSays]

I'll be posting video updates on the healthcare sector when time permits - here is today's edition: http://t.co/esbwKVL137 #asx

[Scott Power @ScottPowerSays]

Back from annual leave and feeling refreshed. I'll be updating our healthcare stocks milestone table in the weeks ahead. #ASX

[Morgans Financial Limited @morgansAU]

Morgans Blog: Snr Analyst Scott Power on the major milestone achievement for Impedimed ($IPD) http://t.co/DunkbGrho5 #ASX #ausbiz

[Scott Power @ScottPowerSays]

Impedimed ($IPD) share price up in a soft market - often a strong sign. Reimbursement newsflow 1st wk Nov. SP target A$0.72 #ASX #ausbiz

[Scott Power @ScottPowerSays]

Admedus ($AHZ) - a high conviction call. Manufacturing plant opens today. Outlook for CardioCel is exciting: http://t.co/jn5ERcE1tx #ASX

[Scott Power @ScottPowerSays]

Volumes and share price for Impedimed ($IPD) are up and SP looks to be going higher. Federal registry announcement expected shortly.

[Scott Power @ScottPowerSays]

Acrux ($ACR) a great run on Friday (+30%) - has run through our price target and we suggest taking profits. #ASX #ausbiz #markets

[Scott Power @ScottPowerSays]

Innate Therapeutics ($IIL) is expected to start its MS trial in Aus in August. Key milestone - buy at A$0.19 for a run to mid 20s #ASX

[Scott Power @ScottPowerSays]

Acrux ($ACR) update - Eli Lilly posts a solid quarterly result for Axiron. The market should like it and traders can take some profit. #ASX

[Scott Power @ScottPowerSays]

I'm back from the Bioshares conference. A highlight was Impedimed ($IPD). Upgraded reimbursement code is the key - expect before end of Oct.

[Morgans Financial Limited @morgansAU]

Snr Analyst Scott Power with his 3 companies to watch from the Bioshares Biotech Summit: http://t.co/nIQftBJFj7 #ASX #ausbiz